1-[(1S,5R)-10,10-dimethyl-3,3-dioxido-3-thia-4-azatricyclo[5.2.1.0^1.5]dec-4-yl]-ethanone | 141993-16-0

• 物质功能分类: 生物化工 - 多肽
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 1-[(1S,5R)-10,10-dimethyl-3,3-dioxido-3-thia-4-azatricyclo[5.2.1.0^1.5]dec-4-yl]-ethanone
• 英文别名: N-acetyl-(2R)-bornane-10,2-sultam；(2R)-N-acetylbornanesultam；(1S,2R)-N-(Acetyl)bornane-10,2-sultam；(3aS,6R,7aR)-1-acetylhexahydro-8,8-dimethyl-3H-3a,6-methano-2,1-benzisothiazole 2,2-dioxide；1-((3aS,6R,7aR)-8,8-dimethyl-2,2-dioxidohexahydro-1H-3a,6-methanobenzo[c]isothiazol-1-yl)ethanone；1-[(1S,5R,7R)-10,10-dimethyl-3,3-dioxo-3λ6-thia-4-azatricyclo[5.2.1.01,5]decan-4-yl]ethanone
• CAS: 141993-16-0
• 化学式: C₁₂H₁₉NO₃S
• 分子量: 257.354
• InChiKey: FECARJHVTMSYSJ-CKYFFXLPSA-N

物化性质

• 熔点：
  133-135 °C
• 沸点：
  371.4±25.0 °C(Predicted)
• 密度：
  1.1945 (rough estimate)
• 稳定性/保质期：
  遵循规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  62.8
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  29349990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  存储于阴凉干燥处。

SDS

Name:	(N-Acetyl)-(2R)-bornane-10 2-sultam Material Safety Data Sheet
Synonym:	None Known
CAS:	141993-16-0

Section 1 - Chemical Product MSDS Name:(N-Acetyl)-(2R)-bornane-10 2-sultam Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
141993-16-0	(N-Acetyl)-(2R)-bornane-10,2-sultam	100	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 141993-16-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H19NO3S
Molecular Weight: 257.1979

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 141993-16-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(N-Acetyl)-(2R)-bornane-10,2-sultam - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 141993-16-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 141993-16-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 141993-16-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-[(1S,5R)-10,10-dimethyl-3,3-dioxido-3-thia-4-azatricyclo[5.2.1.0^1.5]dec-4-yl]-ethanone 在 四氯化钛 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成 (R)-1-((3aS,6R,7aR)-8,8-dimethyl-2,2-dioxidohexahydro-1H-3a,6-methanobenzo[c]isothiazol-1-yl)-3-hydroxy-3-phenylpropan-1-one
  参考文献：
  名称：

  来自N-乙酰基冰片烷10,2-磺胺的光学纯净的结晶性``乙酸盐''-羟醛

  摘要：

  ø的-Silylation Ñ -acetylsultam 2给出ø -silyl- Ñ，ö -ketene缩醛3其经历的TiCl 4促进除了芳族和脂族醛，得到，快速色谱法后，非对映异构纯的结晶羟醛5被容易地转化为对映异构体纯β-羟基羧酸或酯。

  DOI：

  10.1016/s0040-4039(00)92209-3
• 作为产物：
  描述：

  D(+)-10-樟脑磺酸 在 lithium aluminium tetrahydride 、 氯化亚砜 、 sodium hydride 作用下， 以 四氢呋喃 、 氯仿 、 甲苯 、 mineral oil 为溶剂， 反应 35.75h， 生成 1-[(1S,5R)-10,10-dimethyl-3,3-dioxido-3-thia-4-azatricyclo[5.2.1.0^1.5]dec-4-yl]-ethanone
  参考文献：
  名称：

  原位形成的烯丙基半缩醛的钯催化立体选择性环化：瑞舒伐他汀和匹伐他汀的合成

  摘要：

  描述了非对映选择性钯催化的烯丙基半缩醛的环化。它允许选择性合成1，3-二恶烷衍生物，这是在所有他汀类药物代表中出现的顺式1,3-二醇的前体。该反应允许以简单的方式完全合成瑞舒伐他汀和匹伐他汀。

  DOI：

  10.1021/acs.orglett.8b01156

文献信息

• Total Syntheses of Epothilones B and D
  作者：Jae-Chul Jung、Rajashaker Kache、Kimberly K. Vines、Yan-Song Zheng、Panicker Bijoy、Muralikrishna Valluri、Mitchell A. Avery

  DOI：10.1021/jo048742o

  日期：2004.12.1

  A convergent, total synthesis of epothilones B (2) and D (4) is described. The key steps are Normant coupling to establish the desired (Z)-stereochemistry at C12−C13, Wadsworth−Emmons olefination of methyl ketone 28 with the phosphonate ester 8, diastereoselective aldol condensation of aldehyde 5 with the enolate of keto acid derivatives to form the C6−C7 bond, selective deprotection of acid 52, and

  描述了收敛的全合成的埃坡霉素B（2）和D（4）。关键步骤是通过Normant偶联在C12-C13上建立所需的（Z）-立体化学，Wadsworth-Emmons甲基酮28与膦酸酯8的烯键化，醛5与醛酸与酮酸衍生物的烯酸酯的非对映选择性醛醇缩合以形成C6-C7键，酸52的选择性脱保护和大内酯化。
• Diastereoselective synthesis of α-bromo amides leading to diastereomerically enriched α-amino-, α-hydroxy- and α-thiocarboxylic acid derivatives
  作者：By Robert S Ward、Andrew Pelter、Dominique Goubet、Martyn C Pritchard

  DOI：10.1016/0957-4166(95)00032-k

  日期：1995.2

  prepared diastereoselectively starting from racemic α-bromo acids, and undergo epimerisation under appropriate conditions leading to an enhanced d.e.. By reacting the individual isomers or the mixture of diastereoisomers with a suitable nucleophile it is possible to obtain α-substituted carboxylic acids, including α-amino- α-hydroxy- and α-thiocarboxylic acid derivatives, in diastereomerically enriched

  可以从外消旋α-溴酸开始非对映选择性地制备来源于Oppolzer樟脑的α-溴酰胺，并在适当条件下进行差向异构化，从而提高de值。通过使单个异构体或非对映异构体的混合物与合适的亲核试剂反应，可以获得非对映体富集形式的α-取代的羧酸，包括α-氨基-α-羟基和α-硫代羧酸衍生物。
• Epothilone Analogues with Benzimidazole and Quinoline Side Chains: Chemical Synthesis, Antiproliferative Activity, and Interactions with Tubulin
  作者：Silvia Anthoine Dietrich、Renate Lindauer、Claire Stierlin、Jürg Gertsch、Ruth Matesanz、Sara Notararigo、José Fernando Díaz、Karl-Heinz Altmann

  DOI：10.1002/chem.200901376

  日期：2009.10.5

  of quinoline‐based epothilone B and D analogues for stabilized microtubules clearly depends on the position of the N‐atom in the quinoline system, while the induction of tubulin polymerization in vitro appears to be less sensitive to N‐positioning. The potent inhibition of human cancer cell growth by epothilone analogues bearing functionalized benzimidazole side chains suggests that these systems might

  通过化学合成以高度收敛的方式制备了一系列带有异构喹啉或官能化苯并咪唑侧链的埃博霉素B和D类似物。已发现所有类似物均可与微管蛋白/微管系统相互作用，并在体外抑制人癌细胞的增殖，尽管具有不同的效力（IC 50值介于1至150 n M之间）。基于喹啉的埃坡霉素B和D类似物对稳定的微管的亲和力显然取决于N原子在喹啉系统中的位置，而体外对微管蛋白聚合的诱导似乎对N位置的敏感性较低。带有功能化苯并咪唑侧链的埃坡霉素类似物对人癌细胞的有效抑制表明，这些系统可能与靶向肿瘤的部分结合形成靶向肿瘤的前药。
• Total Synthesis and Initial Structure−Function Analysis of the Potent V-ATPase Inhibitors Salicylihalamide A and Related Compounds
  作者：Yusheng Wu、Xibin Liao、Ruifang Wang、Xiao-Song Xie、Jef K. De Brabander

  DOI：10.1021/ja0177713

  日期：2002.4.1

  products that induce a variety of interesting phenotypes in cultured mammalian cells. Salicylihalamide A was reported to be a unique and highly differential cytotoxin and a potent inhibitor of the mammalian vacuolar (H(+))-ATPase. The total synthesis of both enantiomers of salicylihalamide A, a revision of the absolute configuration assigned to the natural product, and extensive structure-function studies

  Salicylihalamide A 是不断增长的一类大环水杨酸盐天然产物的第一个成员，这些产物在培养的哺乳动物细胞中诱导各种有趣的表型。据报道，Salicylihalamide A 是一种独特且高度差异化的细胞毒素，是哺乳动物液泡 (H(+))-ATPase 的有效抑制剂。报告了水杨酰卤 A 的两种对映异构体的全合成、分配给天然产物的绝对构型的修订以及与合成水杨酰卤变体的广泛结构-功能研究。这些研究之所以成为可能，仅是由于一种高效的合成策略，该策略具有以下特点：（1）显着的 E 选择性闭环烯烃复分解反应以构建 12 元苯内酯骨架 29，（2）对 E-烯基异氰酸酯进行温和的立体控制加工 41 , (3) 添加碳，氧和硫亲核试剂生成异氰酸酯 41，得到水杨酰卤酰胺 A 和同系物。我们首次证明水杨酰胺 A 是来自牛脑的完全纯化的重组 V-ATP 酶的有效抑制剂，并且已经确定了几种类似有效的侧链修饰衍生物，包括水杨酰胺二聚体
• Syntheses of isotopically labelled L-α-amino acids with an asymmetric centre at C-3
  作者：John R. Harding、Rachael A. Hughes、Nicholas M. Kelly、Andrew Sutherland、Christine L. Wilis

  DOI：10.1039/b005172l

  日期：——

  Approaches are described to the synthesis of a series of isotopically labelled L-α-amino acids each with an asymmetric centre at C-3, including isoleucine, allo-isoleucine, threonine and allo-threonine. The methods may be simply adapted for the selective incorporation of an isotopic label at each site of L-valine including the selective labelling of either diastereotopic methyl group with carbon-13

  描述了合成一系列同位素标记的L -α-氨基酸的方法，每个氨基酸在C-3处具有不对称中心，包括异亮氨酸， 同种异亮氨酸， 苏氨酸 和 异基因-苏氨酸。所述方法可以简单地适于将同位素标记物选择性地掺入到所述细胞的每个位点。大号缬氨酸 包括对非对映异构体的选择性标记 甲基 碳13和/或氘和 贴标 的 胺 和 氮15。